Home › Funds › Arax Advisory Partners › JNJ

Arax Advisory Partners position in JNJ

JOHNSON & JOHNSON · Health Care

Arax Advisory Partners reported holding 415,395 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$110.0M, representing 0.70% of its reported portfolio and ranking #21 among its reported holdings. Arax Advisory Partners has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)415.39K sh
Reported value held$109.97M
Portfolio Weight0.70%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Arax Advisory Partners's JNJ position evolved

Arax Advisory Partners first disclosed a stake in JNJ in Q3 2023 at 17,290 shares (US$2.7M). The position peaked in Q3 2026 at 415,395 shares, worth US$110.0M. Across 13 filings, Arax Advisory Partners increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 415,395 shares valued at US$110.0M — an increase of 88,605 shares quarter over quarter.. Notable position changes include a 571% increase in Q3 2025 (shares rose 11% over the following quarter), a 77% trim in Q4 2025 (shares rose 18% over the following quarter), a 690% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.29K $2.69M New
Q4 2023 17.04K $2.67M Reduce
Q1 2024 15.27K $2.41M Reduce
Q2 2024 15.62K $2.28M Add
Q3 2024 15.48K $2.51M Reduce
Q4 2024 17.16K $2.48M Add
Q1 2025 16.77K $2.78M Reduce
Q2 2025 20.83K $3.69M Add
Q3 2025 139.73K $25.91M Add
Q4 2025 32.32K $6.69M Reduce
Q1 2026 41.38K $10.12M Add
Q2 2026 326.79K $82.99M Add
Q3 2026 415.39K $109.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Arax Advisory Partners held JNJ?

Arax Advisory Partners has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Arax Advisory Partners's current position in JNJ?

As of Q3 2026, Arax Advisory Partners holds 415.39K shares of JNJ (JOHNSON & JOHNSON), valued at $109.97M, representing 0.70% of its reported portfolio and ranking #21.

Has Arax Advisory Partners been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Arax Advisory Partners increased its position in JNJ. The position peaked in Q3 2026 at 415.39K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.